Phytochemicals in the control of human appetite and body weight

Pharmaceuticals

Volumn 3, Issue 3, 2010, Pages 748-763

  Tucci, Sonia A ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Calories; Energy expenditure; Energy intake; Obesity

Indexed keywords

AMYLASE; ANOREXIGENIC AGENT; ANTIOBESITY AGENT; CAFFEINE; CAFFEINE PRO; CANNABINOID DERIVATIVE; CANNABIS; CARRALLUMA FIMBRIATA EXTRACT; CATECHIN; CATHA EDULIS EXTRACT; CITRUS FRUIT EXTRACT; COLEUS FORSKOHLII EXTRACT; FORSLEAN; GARCINIA CAMBOGIA EXTRACT; GREEN COFFEE BEAN EXTRACT; GREEN TEA EXTRACT; HOODA GORDONII EXTRACT; HOODERMA; HOODIA HG57; HOODIA MAX; HOODIA PURE; HYDROXYCITRIC ACID; KOREAN PINE NUT OIL; LESSERTIA FRUTESCENS EXTRACT; NICOTINE; OAT OIL; OLIBRA; OXEDRINE; PALM OIL; PINNOTHIN; PLACEBO; PLANT MEDICINAL PRODUCT; PURE HOODIA; QUEST GREEN COFFEE; RAPIDSLIM SX; SLIMALUMA; SUPER CITRIMAX; SVETOL; TEAVIGO; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ANOREXIA; APPETITE; CACHEXIA; CALORIC INTAKE; CHOLECYSTOKININ BLOOD LEVEL; CLINICAL TRIAL; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG TARGETING; ENERGY EXPENDITURE; ENZYME INHIBITION; GASTROINTESTINAL DISEASE; HORMONE RELEASE; HUMAN; LOW DRUG DOSE; METABOLIC REGULATION; NAUSEA; OBESITY; PHYTOCHEMISTRY; RESPIRATORY TRACT DISEASE; REVIEW; SIDE EFFECT; STOMACH EMPTYING; UNSPECIFIED SIDE EFFECT; WASTING SYNDROME; WEIGHT CONTROL; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 77950456319     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph3030748     Document Type: Review

References (115)

1. Alper, C.M.; Mattes, R.D. Effects of chronic peanut consumption on energy balance and hedonics. Int. J. Obes. Relat. Metab. Disord. 2000, 26, 1129-1137.
2. Pasman, W.J.; Heimerikx, J.; Rubingh, C.M.; Van den Berg, R.; O'Shea, M.; Gambelli, L.; Hendriks, H.F.; Einerhand, A.W.; Scott, C.; Keizer, H.G.; Mennen, L.I. The effect of Korean pine nut oil on in vitro CCK release, on appetite sensations and on gut hormones in postmenopausal overweight women. Lipids Health Dis. 2008, 7, 10.
3. McLaughlin, J.; Grazia Luca, M.; Jones, M.N.; D'Amato, M.; Dockray, G.; Thompson, D.G. Fatty acid chain length determines cholecystokinin secretion and effect on human gastric motility. Gastroenterology 1999, 116, 46-53.
4. Lawton, C.L.; Delargy, H.J.; Brockman, J.; Smith, F.C.; Blundell, J.E. The degree of saturation of fatty acids influences post-ingestive satiety. Br. J. Nutr. 2000, 83, 473-482.
5. Scott, C.; Pasman, W.; Hiemerikx, J.; Rubingh, C.; Van Den Berg, R.; O'Shea, M.; Gambelli, L.; Hendricks, H.; Mennen, L.; Einerhand, A. Pinnothin™ suppresses appetite in overweight women. Appetite 2007, 49, 330.
6. Hughes, G.M.; Boyland, E.J.; Williams, N.J.; Mennen, L.; Scott, C.; Kirkham, T.C.; Harrold, J.A.; Keizer, H.G.; Halford, J.C. The effect of Korean pine nut oil (PinnoThin) on food intake, feeding behaviour and appetite: a double-blind placebo-controlled trial. Lipids Health Dis. 2008, 7, 6.
7. Burns, A.A.; Livingstone, M.B.; Welch, R.W.; Dunne, A.; Rowland, I.R. Dose-response effects of a novel fat emulsion (Olibra) on energy and macronutrient intakes up to 36 h postconsumption. Eur. J. Clin. Nutr. 2002, 56, 368-377.
8. Diepvens, K.; Soenen, S.; Steijns, J.; Arnold, M.; Westerterp-Plantenga, M. Long-term effects of consumption of a novel fat emulsion in relation to body-weight management. Int. J. Obes. (Lond). 2007, 31, 942-949.
9. Welch, I.; Saunders, K.; Read, N.W. Effect of ileal and intravenous infusions of fat emulsions on feeding and satiety in human volunteers. Gastroenterology 1985, 89, 1293-1297.
10. Welch, I.M.; Sepple, C.P.; Read, N.W. Comparisons of the effects on satiety and eating behaviour of infusion of lipid into the different regions of the small intestine. Gut 1988, 29, 306-311.
11. Diepvens, K.; Steijns, J.; Zuurendonk, P.; Westerterp-Plantenga, M.S. Short-term effects of a novel fat emulsion on appetite and food intake. Physiol. Behav. 2008, 95, 114-117.
12. Burns, A.A.; Livingstone, M.B.; Welch, R.W.; Dunne, A.; Robson, P.J.; Lindmark, L.; Reid, C A.; Mullaney, U.; Rowland, I.R. Short-term effects of yoghurt containing a novel fat emulsion on energy and macronutrient intakes in non-obese subjects. Int. J. Obes. Relat. Metab. Disord. 2000, 24, 1419-1425.
13. Lewis, Y.S.; Neelakantan, S. (-)-Hydroxycitric acid - the principal acid in the fruits of Garcinia cambogia. Desr. Psytochem. 1965, 4, 619-625.
14. Clouatre, D.; Rosenbaum, M.E. The Diet and Health Benefits of HCA. Keats Publishing: New Canaan, CT, USA, 1994.
15. Sergio, W. A natural food, the Malabar Tamarind, may be effective in the treatment of obesity. Med. Hypotheses 1988, 27, 39-40.
16. McCarty, M.; Majeed, M. The pharmacology of Citrin. In Citrin®. A Revolutionary, Herbal Approach to Weight Management; Majeed, M.; Rosen, R.; McCarty, M.; Conte, A.; Patil, D.; Butrym, E., Eds.; New Editions Publishing: Burlingame, CA, USA, 1994; pp. 34-52.
17. Mattes, R.D.; Bormann L. Effects of (-)-hydroxycitric acid on appetitive variables. Physiol. Behav. 2000, 71, 87-94.
18. Heymsfield, S.B.; Allison, D.; Vasselli, J.R.; Pietrobelli, A.; Greenfield, D.; Nuñez, C. Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial. JAMA 1998, 280, 1596-1600.
19. Westerterp-Plantenga, M.S.; Kovacs, E.M. The effect of (-)-hydroxycitrate on energy intake and satiety in overweight humans. Int. J. Obes. Relat. Metab. Disord. 2002, 26, 870-872.
20. Preuss, H.G.; Rao, C.V.; Garis, R.; Bramble, J.D.; Ohia, S.E.; Bagchi, M.; Bagchi, D. An overview of the safety and efficacy of a novel, natural(-)-hydroxycitric acid extract (HCA-SX) for weight management. J. Med. 2004, 35, 33-48.
21. Greenwood, M.R.; Cleary, M.P.; Gruen, R.; Blase, D., Stern, J.S.; Triscari, J.; Sullivan, A.C. Effect of (-)-hydroxycitrate on development of obesity in the Zucker obese rat. Am. J. Physiol. 1981, 240, E72-E78.
22. Korenkov, M.; Sauerland, S.; Junginger, T. Surgery for obesity. Curr. Opin. Gastroenterol. 2005, 21, 679-683.
23. Han, L.K.; Kimura, Y.; Kawashima, M.; Takaku, T.; Taniyama, T.; Hayashi, T.; Zheng, Y.N.; Okuda, H. Anti-obesity effects in rodents of dietary teasaponin, a lipase inhibitor. Int. J. Obes. 2001, 25, 1459-1464.
24. Muramatsu, K.; Fukuyo, M.; Hara, Y. Effect of green tea catechins on plasma cholesterol level in cholesterol-fed rats. J. Nutr. Sci. Vitaminol. 1986, 32, 613-622.
25. Nagao, T.; Komine, Y.; Soga, S.; Meguro, S.; Hase, T.; Tanaka, Y.; Tokimitsu, I. Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men. Am. J. Clin. Nutr. 2005, 81, 122-129.
26. Wolfram, S.; Wang, Y.; Thielecke, F. Anti-obesity effects of green tea: From bedside to bench. Mol. Nutr. Food Res. 2006, 50, 176-187.
27. Sano, M.; Tabata, M.; Suzuki, M.; Degawa, M.; Miyase, T.; Maeda-Yamamoto, M. Simultaneous determination of twelve tea catechins by high-performance liquid chromatography with electrochemical detection. Analyst 2001, 126, 816-820.
28. Mandel, S.A.; Amit, T.; Weinreb, O.; Reznichenko, L.; Youdim, M.B. Simultaneous manipulation of multiple brain targets by green tea catechins: A potential neuroprotective strategy for Alzheimer and Parkinson diseases. CNS Neurosci. Ther. 2008, 14, 352-365.
29. Hase, T.; Komine, Y.; Meguro, S.; Takeda, Y.; Takahashi, H.; Matusi, Y. Anti-obesity effects of tea catechins in humans. J. Oleo. Sci. 2001, 50, 599-605.
30. Tsuchida, T.; Itakura, H.; Nakamura, H. Reduction of body fat in humans by long-term ingestion of catechins. Prog. Med. 2002, 22, 2189-2203.
31. Kovacs, E.M.; Mela, D.J. Metabolically active functional food ingredients for weight control. Obes. Rev. 2006, 7, 59-78.
32. Auvichayapat, P.; Prapochanung, M.; Tunkamnerdthai, O.; Sripanidkulchai, B.O.; Auvichayapat, N.; Thinkhamrop, B.; Kunhasura, S.; Wongpratoom, S.; Sinawat, S.; Hongprapas, P. Effectiveness of green tea on weight reduction in obese Thais: A randomized, controlled trial. Physiol. Behav. 2008, 93, 486-491.
33. Nagao, T.; Hase, T.; Tokimitsu, I. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity (Silver Spring) 2007, 15, 1473-1483.
34. Maki, K.C.; Reeves, M.S.; Farmer, M.; Yasunaga, K.; Matsuo, N.; Katsuragi, Y.; Komikado, M.; Tokimitsu, I.; Wilder, D.; Jones, F.; Blumberg, J.B.; Cartwright, Y. Green tea catechin consumption enhances exercise-induced abdominal fat loss in overweight and obese adults. J. Nutr. 2009, 139, 264-270.
35. Diepvens, K.; Kovacs, E.M.; Vogels, N.; Westerterp-Plantenga, M.S. Metabolic effects of green tea and of phases of weight loss. Physiol. Behav. 2006, 87, 185-191.
36. Chantre, P.; Lairon, D. Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity. Phytomedicine 2002, 9, 3-8.
37. Dulloo, A.G.; Duret, C.; Rohrer, D.; Girardier, L.; Mensi, N.; Fathi, M.; Chantre, P.; Vandermander, J. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am. J. Clin. Nutr. 1999, 70, 1040-1045.
38. Rumpler, W.; Seale, J.; Clevidence, B.; Judd, J.; Willey, E.; Yamamoto, S.; Komatsu, T.; Sawaki, T.; Ishikura, Y.; Hosoda, K. Oolong tea increases metabolic rate and fat oxidation in men. J. Nutr. 2001, 131, 2848-2852.
39. Rudelle, S.; Ferruzzi, M.G.; Cristiani, I.; Moulin, J.; Mace, K.; Acheson, K.J.; Tappy, L. Effect of a thermogenic beverage on 24-hour energy metabolism in humans. Obesity (Silver Spring) 2007, 15, 349-355.
40. del Castillo, M.D.; Ames, J.M.; Gordon, M.H. Effect of roasting on the antioxidant activity of coffee brews. J. Agric. Food Chem. 2002, 50, 3698-3703.
41. Thom, E. The effect of chlorogenic acid enriched coffee on glucose absorption in healthy volunteers and its effect on body mass when used long-term in overweight and obese people. J. Int. Med. Res. 2007, 35, 900-908.
42. Pellati, F.; Benvenuti, S.; Melegari, M.; Firenzuoli, F. Determination of adrenergic agonists from extracts and herbal products of Citrus aurantium L. var. amara by LC. J. Pharm. Biomed. Anal. 2002, 29, 1113-1119.
43. Preuss, H.G.; DiFerdinando, D.; Bagchi, M.; Bagchi, D. Citrus aurantium as a thermogenic, weight-reduction replacement for ephedra: An overview. J. Med. 2002, 33, 247-264.
44. Astrup, A. Thermogenic drugs as a strategy for treatment of obesity. Endocrine 2000, 13, 207-212.
45. National Toxicology Program. NTP toxicology and carcinogenesis studies of ephedrine sulfate (CAS, 134-72-5) in F344/N rats and B6C3F1 mice (Feed Studies). Natl. Toxicol. Program Tech. Rep. Series 1986, 307, 1-186.
46. Haaz, S.; Fontaine, K.R.; Cutter, G.; Limdi, N.; Perumean-Chaney, S.; Allison D.B. Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: An update. Obes. Rev. 2006, 7, 79-88.
47. Fredholm, B.B.; Bättig, K.; Holmén, J.; Nehlig, A.; Zvartau, E.E. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 1999, 51, 83-133.
48. Quarta, D.; Borycz, J.; Solinas, M.; Patkar, K.; Hockemeyer, J.; Ciruela, F.; Lluis, C.; Franco, R.; Woods, A.S.; Goldberg, S.R.; Ferré, S. Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N- methyl-D-aspartate receptor stimulation. J. Neurochem. 2004, 91, 873-880.
49. Diepvens, K.; Westerterp, K.R.; Westerterp-Plantenga, M.S. Obesity and thermogenesis related to the consumption of caffeine, ephedrine, capsaicin, and green tea. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 292, R77-R85.
50. Astrup, A.; Breum, L.; Toubro, S.; Hein, P.; Quaade, F. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial. Int. J. Obes. Relat. Metab. Disord. 1992, 16, 269-277.
51. Pasman, W.J.; Westerterp-Plantenga, M.S.; Saris, W.H. The effectiveness of long-term supplementation of carbohydrate, chromium, fibre and caffeine on weight maintenance. Int. J. Obes. Relat. Metab. Disord. 1997, 21, 1143-1151.
52. Westerterp-Plantenga, M.S.; Lejeune, M.P.; Kovacs, E.M. Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation. Obes. Res. 2005, 13, 1195-1204.
53. Tremblay, A.; Masson, E.; Leduc, S.; Houde, A.; Despres J.P. Caffeine reduces spontaneous energy intake in men but not in women. Nutr. Res. 1988, 8, 553-558.
54. Racotta, S.; Leblanc, J.; Richard, D. The effect of caffeine on food intake in rats: Involvement of corticotropin-releasing factor and the sympatho-adrenal system. Pharmacol. Biochem. Behav. 1994, 48, 887-892.
55. Comer, S.D.; Haney, M.; Foltin, R.W.; Fischman, M.W. Effects of caffeine withdrawal on humans living in a residential laboratory. Exp. Clin. Psychopharmacol. 1997, 5, 399-403.
56. Belza, A.; Toubro, S.; Astrup, A. The effect of caffeine, green tea and tyrosine on thermogenesis and energy intake. Eur. J. Clin. Nutr. 2009, 63, 57-64.
57. Jessen, A.; Buemann, B.; Toubro, S.; Skovgaard, I.M.; Astrup, A. The appetite-suppressant effect of nicotine is enhanced by caffeine. Diab. Ob. Metab. 2005, 7, 327-333.
58. Lopez-Garcia, E.; van Dam, R.M.; Rajpathak, S.; Willett, W.C.; Manson, J.E.; Hu, F.B. Changes in caffeine intake and long-term weight change in men and women. Am. J. Clin. Nutr. 2006, 83, 674-680.
59. Acheson, K.J.; Zahorska-Markiewicz, B.; Pittet, P.; Anantharaman, K.; Jequier, E. Caffeine and coffee: Their influence on metabolic rate and substrate utilization in normal weight and obese individuals. Am. J. Clin. Nutr. 1980, 33, 989-997.
60. Jung, R.T.; Shetty, P.S.; James, W.P.; Barrand, M.A.; Callingham, B.A. Caffeine: Its effect on catecholamines and metabolism in lean and obese humans. Clin. Sci. (Lond.) 1981, 60, 527-535.
61. Hollands, M.A.; Arch, J.R.; Cawthorne, M.A. A simple apparatus for comparative measurements of energy expenditure in human subjects: The thermic effect of caffeine. Am. J. Clin. Nutr. 1981, 34, 2291-2294.
62. Graham, T.E. Caffeine and exercise: Metabolism, endurance and performance. Sports Med. 2001, 31, 785-807.
63. Taylor, P. Ganglionic stimulating and blocking agents. In The Pharmacological Basis of Therapeutics; Oillman, A.G., Goodman, L., Rail, T.W., Murad, F., Eds.; McMillan; New York, NY, USA, 1985.
64. Perkins, K.A.; Epstein, L.H; Stiller, R.L.; Fernstrom, M.H.; Sexton, J.E.; Jacob, R.G.; Solberg, R. Acute effects of nicotine on hunger and caloric intake in smokers and nonsmokers. Psychopharmacology 1991, 103, 103-109.
65. Dallosso, H.M.; James, W.P. The role of smoking in the regulation of energy balance. Int. J. Obes. 1984, 8, 365-375.
66. Albanes, D.; Jones, D.Y.; Micozzi, M.S.; Mattson, M.E. Associations between smoking and body weight in the U.S. population: Analysis of NHANES II. Am. J. Public Health 1987, 77, 439-444.
67. Jo, Y.H.; Talmage, D.A.; Role, L.W. Nicotinic receptor-mediated effects on appetite and food intake. J. Neurobiol. 2002, 53, 618-632.
68. Williamson, D.F.; Madans, J.; Anda, R.F.; Kleinman, J.C.; Giovino, G.A.; Byers, T. Smoking cessation and severity of weight gain in a national cohort. N. Engl. J. Med. 1991, 324, 739-745.
69. Shimokata, H.; Muller, D.C.; Andres R. Studies in the distribution of body fat. III. Effects of cigarette smoking. JAMA 1989, 261, 1169-1173.
70. Flegal, K.M.; Troiano, R.P.; Pamuk, E.R.; Kuczmarski, R.J.; Campbell, S.M. The influence of smoking cessation on the prevalence of overweight in the United States. N. Engl. J. Med. 1995, 333, 1165-1170.
71. Huot, I.; Paradis, G.; Ledoux, M. Quebec Heart Health Demonstration Project Research Group. Factors associated with overweight and obesity in Quebec adults. Int. J. Obes. Relat. Metab. Disord. 2004, 28, 766-774.
72. Grunberg, N.E.; Bowen, D.J.; Winders, S.E. Effects of nicotine on body weight and food consumption in female rats. Psychopharmacology (Berl.) 1986, 90, 101-105.
73. Klesges, R.C.; Meyers, A.W.; Klesges, L.M.; La Vasque, M.E. Smoking, body weight, and their effects on smoking behavior: A comprehensive review of the literature. Psychol. Bull. 1989, 106, 204-230.
74. Pomerleau, C.S. Issues for women who wish to stop smoking, In Helping the hard-core smoker, Seidman, D. F.; Covey, L.S., Eds.; Lawrence Erlbaum: London, UK, 1999; pp. 73-91.
75. Pomerleau, C.S.; Pomerleau, O.F.; Namenek, R.J.; Mehringer, A.M. Short-term weight gain in abstaining women smokers. J. Subst. Abuse Treat. 2000, 18, 339-342.
76. Blaha, V.; Yang, Z.J.; Meguid, M.; Chai, J.K.; Zadak, Z. Systemic nicotine administration suppresses food intake via reduced meal sizes in both male and female rats. Acta Med. 1998, 41, 167-173.
77. Miyata, G.; Meguid, M.M.; Varma, M.; Fetissov, S.O.; Kim, H.J. Nicotine alters the usual reciprocity between meal size and meal number in female rat. Physiol. Behav. 2001, 74, 169-176.
78. Filozof, C.; Fernandez Pinilla, M.C.; Fernandez-Cruz, A. Smoking cessation and weight gain. Obes. Rev. 2004, 5, 95-103.
79. Gross, J.; Stitzer, M.L.; Maldonado, J. Nicotine replacement: Effects of postcessation weight gain. J. Consult. Clin. Psychol. 1989, 57, 87-92.
80. Allen, S.S.; Hatsukami, D.; Brintnell, D.M.; Bade, T. Effect of nicotine replacement therapy on post-cessation weight gain and nutrient intake: A randomized controlled trial of postmenopausal female smokers. Addict. Behav. 2005, 30, 1273-1280.
81. Le Bras, M.; Fretillere, Y. Les aspects mrdicaux de la consommation habituelle du Cath. Mdd. trop. 1965, 25, 720-731.
82. Halbach, H. Medical aspects of the chewing of khat leaves. Bull. World Health Org. 1972, 47, 21-29.
83. Zelger, J.L.; Carlini, E.A. Anorexigenic effects of two amines obtained from Catha edulis Forsk. (Khat) in rats. Pharmacol. Biochem. Behav. 1980, 12, 701-705.
84. Toennes, S.W.; Harder, S.; Schramm, M.; Niess, C.; Kauert, G.F. Pharmacokinetics of cathinone, cathine and norephedrine after the chewing of khat leaves. Br. J. Clin. Pharmacol. 2003, 56, 125-130.
85. Heymann, T.D.; Bhupulan, A.; Zureikat, N.E.; Bomanji, J.; Drinkwater, C.; Giles, P.; Murray-Lyon, I.M. Khat chewing delays gastric emptying of a semi-solid meal. Aliment. Pharmacol. Ther. 1995, 9, 81-83.
86. Murray, C.D.; Le Roux, C.W.; Emmanuel, A.V.; Halket, J.M.; Przyborowska, A.M.; Kamm, M.A.; Murray-Lyon, I.M. The effect of Khat (Catha edulis) as an appetite suppressant is independent of ghrelin and PYY secretion. Appetite 2008, 51, 747-750.
87. Van Beek, T.A.; Verpoorte, R.; Svendsen, A.B.; Leeuwenberg, A.J.; Bisset, N.G. Tabernaemontana L. (Apocynaceae): A review of its taxonomy, phytochemistry, ethnobotany and pharmacology. J. Ethnopharmacol. 1984, 10, 1-156.
88. van Heerden, F.R. Hoodia gordonii: A natural appetite suppressant. J. Ethnopharmacol. 2008, 119, 434-437.
89. MacLean, D.B.; Luo, L.G. Increased ATP content/production in the hypothalamus may be a signal for energy-sensing of satiety: Studies of the anorectic mechanism of a plant steroidal glycoside. Brain Res. 2004, 1020, 1-11.
90. MacLean, D.B. Abrogation of peripheral cholecystokinin-satiety in the capsaicin treated rat. Regul. Pept. 1985, 11, 321-333.
91. Phytopharm plc. Phytopharm Open Offer and Placing Prospectus 080228. 2008.
92. Bader, A.; Braca, A.; De Tommasi, N.; Morelli, I. Further constituents from Caralluma negevensis. Phytochemistry 2003, 62, 1277-1281.
93. Preuss, H.G.; Bagchi, D.; Bagchi, M.; Rao, C.V.; Dey, D.K.; Satyanarayana, S. Effects of a natural extract of (-)-hydroxycitric acid (HCA-SX) and a combination of HCA-SX plus niacinbound chromium and Gymnema sylvestre extract on weight loss. Diabetes Obes. Metab. 2004, 6, 171-180.
94. Preuss, H.G. Report on the Safety of Caralluma Fimbriata and its Extract; Gencor Nutrients: Washington, DC, USA, 2004.
95. Kuriyan, R.; Raj, T.; Srinivas, S.K.; Vaz, M.; Rajendran, R.; Kurpad, A.V. Effect of Caralluma fimbriata extract on appetite, food intake and anthropometry in adult Indian men and women. Appetite 2007, 48, 338-344.
96. Roberts, S.B.; Heyman, M.B. Dietary composition and obesity: Do we need to look beyond dietary fat? J. Nutr. 2000, 130, 267S.
97. Caprioli, J.; Sears, M. Forskolin lowers intraocular pressure in rabbits, monkeys, and man. Lancet 1983, 1, 958-960.
98. Burns, T.W.; Langley, P.E.; Terry, B.E; Bylund, D.B.; Forte, L.R.J. Comparative effects of forskolin and isoproterenol on the cyclic AMP content of human adipocytes. Life Sci. 1987, 40, 145-154.
99. Litosch, I.; Hudson, T.H.; Mills, I.; Li, S.Y.; Fain, J.N. Forskolin as an activator of cyclic AMP accumulation and lipolysis in rat adipocytes. Mol. Pharmacol. 1982, 22, 109-115.
100. Henderson, S.; Magu, B.; Rasmussen, C, Lancaster, S.; Kerksick, C.; Smith, P.; Melton, C.; Cowan, P.; Greenwood, M.; Earnest, C.; Almada, A.; Milnor, P.; Magrans, T.; Bowden, R.; Ounpraseuth, S.; Thomas, A.; Kreider, R.B. Effects of coleus forskohlii supplementation on body composition and hematological profiles in mildly overweight women. J. Int. Soc. Sports Nutr. 2005, 2, 54-62.
101. Greenberg, I.; Kuehnle, J.; Mendelson, J.H.; Bernstein, J.G. Effects of marihuana use on body weight and caloric intake in humans. Psychopharmacology (Berl.) 1976, 49, 79-84.
102. Foltin, R.W.; Brady, J.V.; Fischman, M.W. Behavioral analysis of marijuana effects on food intake in humans. Pharmacol. Biochem. Behav. 1986, 25, 577-582.
103. Foltin, R.W.; Fischman, M.W; Byrne, M.F. Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory. Appetite 1988, 11, 1-14.
104. Haney, M; Rabkin, J.; Gunderson, E.; Foltin, R.W. Dronabinol and marijuana in HIV+ marijuana smokers: Acute effects on caloric intake and mood. Psychopharmacology (Berl.) 2005, 181, 170-178.
105. Hart, C.L.; Ward, A.S.; Haney, M.; Comer, S.D.; Foltin, R.W.; Fischman, M.W. Comparison of smoked marijuana and oral D9-tetrahydrocannbinol in humans. Psychopharmacology (Berl.) 2002, 164, 407-415.
106. Haney, M.; Ward, A.S.; Comer, S.D.; Foltin, R.W.; Fischman, M.W. Abstinence symptoms following oral THC administration to humans. Psychopharmacology (Berl.) 1999, 141, 385-394.
107. Haney, M.; Gunderson, E.W.; Rabkin, J.; Hart, C.L.; Vosburg, S.K.; Comer, S.D.; Foltin, R.W. Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 2007, 45, 545-554.
108. Abel, E.L. Effects of marijuana on the solution of anagrams, memory and appetite. Nature 1971, 231, 260-261.
109. Hollister, L.E. Hunger and appetite after single doses of marihuana, alcohol, and dextroamphetamine. Clin. Pharmacol. Ther. 1971, 12, 44-49.
110. Regelson, W.; Butler, J.R.; Schultz, J. Delta-9-tetrahydrocannabinol as an effective antidepressant and appetitestimulating agent in advanced cancer patients. In The Pharmacology of Marijuana; Braude, M., Szara, S., Eds.; Raven Press: New York, USA, 1976; pp. 763-776.
111. Beal, J.E.; Olson, R.; Laubenstein, L.; Morales, J.O.; Bellman, P.; Yangco, B.; Lefkowitz, L.; Plasse, T.F.; Shepard, K.V. Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J. Pain Symptom Manage. 1995, 10, 89-97.
112. Plasse, T.F.; Gorter, R.W.; Krasnow, S.H.; Lane M.; Shepard, K.V.; Wadleigh, R.G. Recent clinical experience with dronabinol. Pharmacol. Biochem. Behav. 1991, 40, 695-700.
113. Struwe, M.; Kaempfer, S.; Geiger, C.; Pavia, A.T.; Plasse, T.F.; Shepard, K.V.; Ries, K.; Evans, T.G. Effect of dronabinol on nutritional status in HIV infection. Ann. Pharmacother. 1993, 27, 827-831.
114. van Wyk, B.E.; Albrecht C. A review of the taxonomy, ethnobotany, chemistry and pharmacology of Sutherlandia frutescens (Fabaceae). J. Ethnopharmacol. 2008, 119, 620-629.
115. Johnson, Q.; Syce, J.; Nell, H.; Rudeen, K.; Folk, W.R. A randomized, double-blind, placebo- controlled trial of Lessertia frutescens in healthy adults. PLoS Clin. Trials 2007, 2, e16.